GlaxoSmithKline Pharma Q1 Results: Net profit rises 11% to Rs 132 cr
Despite the strong external headwinds, GSK remains focused on delivering best-in-class competitive performance and driving operational efficiencies. We remain committed to explore new growth opportunities and improving our leadership in key therapy areas,” GlaxoSmithKline Pharmaceuticals MD Bhushan Akshikar said.
